Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Preclinical Imaging Market In 2029?

Over the past few years, the preclinical imaging market has exhibited robust growth. It is projected to increase from $3.46 billion in 2024 to $3.69 billion in 2025, with a compound annual growth rate (CAGR) of 6.5%. The surge during the historical period can be traced back to government initiatives, the rise in disease prevalence, widened applications, heightened awareness, and growth in emerging markets.

The size of the preclinical imaging market is projected to witness robust growth in the upcoming years, poised to increase to$4.81 billion in 2029 with a compounded annual growth rate (CAGR) of 6.9%. Primary factors driving growth during the forecast period include the rise in personalized medicine, improvements in molecular imaging, outsourcing of drug development, supportive regulations, and an increase in chronic diseases. Key trends projected during this period are the development of green imaging technologies, advancements in technology, an escalation in R&D activities, partnerships and collaborations, and the application of real-time imaging.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

What Are the Core Growth Drivers Propelling the Preclinical Imaging Market Forward?

The preclinical imaging market’s growth is projected to be driven by the rise in chronic illnesses. Chronic diseases, defined as health issues lasting for over three months, generally require continuous medical intervention and significantly influence an individual’s quality of life. To diagnose these persistent ailments, preclinical imaging instruments are employed to depict bone structures and lung functionality. These tools also facilitate the study of disease progression to enhance understanding of chronic diseases. For example, the World Health Organization’s (WHO) 2022 Highlights stated in September 2022 that noncommunicable diseases (NCDs) or chronic diseases globally caused 74% of all deaths, totaling 41 million. These fatalities include 17.9 million from cardiovascular diseases, 9.3 million from cancer, 4.1 million from respiratory diseases, and 2.0 million from diabetes. Consequently, the escalating prevalence of chronic diseases is fueling the enlargement of the preclinical imaging market.

What Segment Types Define the Preclinical Imaging Market Structure?

The preclinical imagingmarket covered in this report is segmented –

1) By Modality: Optical Imaging Systems; Preclinical Nuclear Imaging Systems; Micro-Magnetic Resonance Imaging Systems; Micro-Ultrasound Systems; Micro-Computed Tomography Systems; Preclinical Photoacoustic Imaging Systems; Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents; Preclinical Nuclear Imaging Reagents; Preclinical MRI Contrast Agents; Preclinical Ultrasound Contrast Agents; Preclinical CT Contrast Agents

3) By End User: Hospital; Diagnostics Center; Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging; Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET); Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems; Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging; Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems; Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging; Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking; MPI For Vascular Imaging

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Preclinical Imaging Market?

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Emerging Trends that Are Influencing thePreclinical Imaging Industry Evolution?

There is a growing trend of product innovations in the preclinical imaging market. Primary businesses in this market are creating cutting-edge products to maintain their market presence. For example, Fujifilm VisualSonics Inc., a biomedical firm based in Canada specializing in the manufacture of imaging systems, introduced the VevoF2 for preclinical imaging in May 2022. This groundbreaking product is the inaugural preclinical imaging system which shifts between extremely high and low frequencies (71 MHz-1 MHz), utilizing both ultrasonic and photoacoustic technologies. The Vevo F2 boasts HD image processing technology and a freshly developed signal pathway which enhance image crispness and frame rates. The system can also be tailored to meet specific imaging precision requirements. Furthermore, it comprises features like HD image processing technology, a new signal pathway, system flexibility, a broad variety of anatomical targets, and superior resolution imaging, making it suitable for a range of research uses.

View the full report here:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

What Is the Definition of the Preclinical Imaging Market?

Preclinical imaging refers to the techniques used to visualize and study biological processes in animal models before being applied to human clinical trials. These imaging techniques allow researchers to track disease progression, evaluate the efficacy and safety of potential therapeutics, and gain insights into the biological mechanisms underlying diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12393

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model